Effects of LX4211, a Dual SGLT1/SGLT2 Inhibitor, Plus Sitagliptin on Postprandial Active GLP-1 and Glycemic Control in Type 2 Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of LX4211, a Dual SGLT1/SGLT2 Inhibitor, Plus Sitagliptin on Postprandial Active GLP-1 and Glycemic Control in Type 2 Diabetes

Published:2013-03 Issue:3 Volume:35 Page:273-285.e7
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Zambrowicz Brian,Ding Zhi-Ming,Ogbaa Ike,Frazier Kenny,Banks Phillip,Turnage Anne,Freiman Joel,Smith Melinda,Ruff Dennis,Sands Arthur,Powell David

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference63 articles.

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;N Engl J Med,1993

2. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes;Nathan;N Engl J Med,2005

3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);Lancet,1998

4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998

5. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive in-vitro/in-vivo screening toolbox for the elucidation of glucose homeostasis modulating properties of plant extracts (from roots) and its bioactives;Frontiers in Pharmacology;2024-06-26

2. Exploring the modulatory effects of sotagliflozin on dyslipidemia in mice: The role of glucagon, fibroblast growth factor 21 and glucagon‐like peptide 1;Clinical and Experimental Pharmacology and Physiology;2024-03-25

3. A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin;Clinical Pharmacology & Therapeutics;2024-03-08

4. SGLT2 inhibitors in peritoneal dialysis: a promising frontier toward improved patient outcomes;Renal Replacement Therapy;2024-01-31

5. Sotagliflozin: Efficacy, Safety, and Potential Therapeutic Applications in Heart Failure;Annals of Pharmacotherapy;2023-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3